Maquet Cardiovascular recalled 16,512 Heartstring III Proximal Seal Systems due to critical failure modes. The recall affects devices distributed globally since August 15, 2025. Users must stop using the device immediately and follow manufacturer instructions.
Three failure modes have been identified: failure of the Heartstring Seal to load, failure of the Heartstring Seal to deploy into the aortotomy, and failure of the deployed Heartstring Seal to provide adequate hemostasis.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Maquet Cardiovascular, LLC or your healthcare provider for instructions. Notification method: Letter
The Heartstring III Proximal Seal System, Model No. HSK-3043, has 16,512 units recalled. It was distributed worldwide, including the US and multiple countries, since August 15, 2025.
Three failure modes have been identified: failure of the Heartstring Seal to load, failure to deploy into the aortotomy, and failure to provide adequate hemostasis. These issues pose a significant risk during medical procedures.
The recall does not specify the number of reported incidents or injuries associated with this device. However, the identified failure modes suggest a high potential for serious complications.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by Maquet Cardiovascular, LLC. Contact your healthcare provider for further guidance.
For more information, contact Maquet Cardiovascular, LLC or visit the FDA recall page at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=Z-2588-2025.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.